Clinical trial
The Factors Affecting IPP in Peritoneal Dialysis Patients with Polycystic Kidney Disease
NCT06841224 is registered in ClinicalTrials.gov with Peking University First Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Factors Affecting IPP in Peritoneal Dialysis Patients with Polycystic Kidney Disease
- Lead sponsor
- Peking University First Hospital
- Phase
- Observational
- Overall status
- Enrolling by invitation
- Start date
- April 1, 2024
- Completion date
- March 30, 2025
- Enrollment
- 30 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
peritoneal dialysis, polycystic kidney diseases